Atlas Trials

Effects of the Sherborne Developmental Movement Program on Motor Performance in Children With Autism Spectrum Disorders

Clinical trial NCT06766942 · COMPLETED

Trial details

NCT number
NCT06766942
Sponsor
Elif Dilan ATILGAN
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2025-09-01
Primary completion
2025-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.